查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1858784

活性素A：全球市場佔有率和排名、總銷售額和需求預測（2025-2031年）

Activin A - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球 Activin A 市場規模估計為 2,053 萬美元，預計到 2031 年將達到 4,734 萬美元，在 2025 年至 2031 年的預測期內，複合年成長率為 12.5%。

本報告對近期關稅調整和國際戰略反制措施對Activin A跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響進行了全面評估。

激活素是一種二硫鍵連接的二聚體蛋白，屬於TGF-BETA超家族，最初是從性腺液中純化得到的，用於促進促睪固酮（FSH）的釋放。激活素蛋白具有廣泛的生物活性，包括參與中胚層誘導、神經元分化、骨骼重塑、造血和生殖生理等過程。激活素異構體和其他TGF-BETA超家族成員透過與I型和II型絲胺酸/蘇胺酸激酶受體的異源複合物結合發揮其生物學效應，這些受體對於訊號傳導至關重要。 2024年，全球激活素A的產量約為1115毫克，全球平均市場價格約為18.4美元/微克。

生殖和內分泌健康問題（例如癌症、纖維化疾病、卵巢症候群 (PCOS) 和不孕症）的日益增多，正推動對新型診斷標記和治療標靶的快速需求。激活素 A 在細胞訊號傳導、免疫調節和組織重塑中發揮核心作用，這引起了生物製藥公司和學術研究人員的關注。此外，再生醫學和幹細胞療法的進展也推動了對調控幹細胞命運和組織修復因子的需求，而激活素 A 在其中佔據著尤為重要的地位。生物技術創新——例如改進的重組表達系統、增強的純化和穩定性以及最佳化的遞送系統——降低了生產成本和品質風險，從而使其應用範圍從高階研究擴展到診斷和治療產品。許多國家政府和監管政策以及公共資金對生物標記和精準醫療的支持，進一步拓展了市場成長機會。

儘管有許多機遇，激活素A市場也面臨重大風險。首先，激活素A的生物機制複雜且高度依賴具體情況。其作用可能因疾病狀態、劑量、給藥時間及組織類型而異，既可能帶來益處，也可能造成損害。這使得中和劑和拮抗劑的治療設計變得複雜，並增加了安全性和有效性的不確定性。其次，從研發到臨床試驗的過程漫長且高成本。在動物模型和人體中驗證特定適應症的有效性和安全性需要大量的時間和資金投入，這構成了一大障礙，尤其對於中小企業而言。第三，不同地區的監理核准流程差異顯著。品質、安全性、劑型、聯合治療和生物標記檢驗等方面的要求各不相同，監管政策的變更和延誤可能會延長產品上市時間。此外，成熟的生物技術/製藥公司、學術研究機構和Start-Ups之間的競爭日益激烈，因此，差異化、智慧財產權保護和有效的商業化策略至關重要。

下游需求正從純粹的研究試劑轉向診斷和治療組合產品。儘管研究機構仍在購買激活素A蛋白、抗體和檢測試劑套件，但診斷實驗室和臨床機構擴大將激活素A作為疾病（癌症、纖維化和發炎性疾病）早期檢測的生物標記。生物製藥公司正在開發針對激活素A的治療藥物（中和抗體、受體拮抗劑），用於抗纖維化、腫瘤抑制和促進組織再生等適應症。精準醫療/個人化治療策略強調監測激活素A的濃度或活性，以進行患者分層。從區域來看，新興地區（亞洲、拉丁美洲和中東）正在增加對醫療研究基礎設施的投資，與成熟市場相比，這推動了激活素A相關產品需求的更快成長。

上游工程原料包括重組激活素A表達系統（例如，細菌、酵母和哺乳動物細胞株）、培養基和組分、純化培養基和緩衝液、穩定性增強劑、品管試劑和分析試劑，以及中和抗體或拮抗劑。單線生產能力是指從表達→純化→品管→製劑/穩定性測試（液體/冷凍乾燥）→包裝和分銷的完整生產線。在這個生產線中，表達系統的選擇和正確的折疊/修飾是關鍵瓶頸。純化和去除內毒素及非預期雜質需要先進的技術。品管，包括生物活性測試和安全檢驗，決定了產品是否達到臨床級標準或仍處於研究級標準。研究試劑/ELISA級激活素A產品具有單線部署前置作業時間短、投資成本低的優點。然而，治療性產品（尤其是中和抗體、受體拮抗劑或透過新型遞送系統遞送的產品）需要更多的資金、設施、熟練的人員以及更長的研發和檢驗週期。

本報告旨在對全球 Activin A 市場按地區/國家、類型和應用進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

本報告以銷售量（毫克）和收入（百萬美元）為單位，提供Activin A的市場規模、估算和預測，基準年為2024年，並包含2020年至2031年的歷史數據和預測數據。定量和定性分析相結合，幫助讀者制定業務/成長策略、評估市場競爭、分析自身在當前市場中的地位，並就Activin A做出明智的商業決策。

市場區隔

公司

  • Merck Millipore
  • Thermo Fisher Scientific
  • Bio-Techne
  • StemRD
  • Prospec
  • Proteintech Group
  • Ajinomoto
  • Enzo Life Sciences
  • IBL
  • STEMCELL
  • Sino Biological
  • PeproTech
  • ReproCELL

按類型分類的細分市場

  • 人類激活素A
  • Activin A 小鼠（大鼠）

應用領域

  • 商業研究
  • 學術研究

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Activin A was estimated to be worth US$ 20.53 million in 2024 and is forecast to a readjusted size of US$ 47.34 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Activin A cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological activities, including mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis and roles in reproductive physiology. Activin isoforms and other members of the TGF-beta superfamily exert their biological effects by binding to heteromeric complexes of a type I and a type II serine-threonine kinase receptor, both of which are essential for signal transduction.In 2024, global Activin A production reached approximately 1115 mg, with an average global market price of around 18.4 USD/µg

With the rising incidence of cancers, fibrotic disorders, and reproductive / endocrine health issues such as PCOS or infertility, there is sharply increasing demand for novel diagnostic markers and therapeutic targets. Activin A's central role in cellular signaling, immune modulation and tissue remodeling is drawing heightened attention from biopharma and academic researchers. In addition, the rise of regenerative medicine and stem cell therapies fuels demand for factors that can regulate stem cell fate and tissue repair, among which Activin A is prominent. Biotechnology innovations-improvements in recombinant expression systems, purification and stability enhancements, as well as delivery system optimization-are reducing production costs and risks of quality, enabling broader application from only high-end research to diagnostics and therapeutic products. Government and regulatory policies in many countries supporting biomarkers and precision medicine, along with public funding, further release opportunities for market growth.

Despite many opportunities, the Activin A market faces notable risks. First, the biological mechanisms of Activin A are complex and highly context-dependent: its effects may be beneficial or harmful depending on disease state, dose, timing and tissue, which complicates therapeutic designs of neutralizing agents or antagonists and raises safety/efficacy uncertainties. Second, the R&D to clinical clinical trial path is long and expensive; proving efficacy and safety in specific indications in animal models and humans requires substantial investment in time and money, which is a barrier especially for smaller firms. Third, regulatory approval pathways vary widely across geographies: quality, safety, delivery format, combination therapies, and biomarker validation are addressed differently, and changes or delays in regulation can lengthen time to market. Also, competition is intensifying among established biotech / pharmaceutical companies, academic labs, and startups; differentiation, intellectual property protection, and effective commercialization strategies become critical.

Downstream demand is shifting from purely research reagents toward combined diagnostics + therapeutics. Research institutions continue to purchase Activin A proteins, antibodies, and assay kits, but diagnostic laboratories and clinical settings are increasingly adopting Activin A as a biomarker for early disease detection (cancer, fibrosis, inflammatory diseases). Biopharma firms are progressing therapeutic development targeting Activin A (neutralizing antibodies, receptor antagonists) in indication areas such as antifibrosis, tumor suppression, and enhancing tissue regeneration. Precision medicine / personalized therapeutic strategies are favoring monitoring of Activin A levels or activity for patient stratification. Geographically, emerging regions (Asia, Latin America, Middle East) are increasing their investment in health research infrastructure, so demand growth in Activin A-related products is accelerating there relative to mature markets

Upstream raw inputs include recombinant Activin A expression systems (e.g. bacterial, yeast, mammalian cell lines), culture media and components, purification media and buffers, stability enhancers, QC reagents and analytical assays, antibodies or antagonists for neutralization, etc. A single-line capacity refers to a full production line from expression -> purification -> quality control -> formulation/stability (liquid / freeze-dried) -> packaging & distribution. Within such a line, expression system choice and correct folding / modification are key bottlenecks; purification and removal of endotoxins or unintended impurities are demanding; QC including bioactivity assays and safety validations determine whether outputs meet clinical-grade or just research-grade standards. Research reagent / ELISA-level Activin A products have shorter lead times and lower investment for single-line deployment; but therapeutic products-especially neutralizing antibodies, receptor antagonists, or those delivered via novel delivery systems-require much larger capital, facilities, skilled personnel, and longer development & validation times.

This report aims to provide a comprehensive presentation of the global market for Activin A, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Activin A by region & country, by Type, and by Application.

The Activin A market size, estimations, and forecasts are provided in terms of sales volume (mg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Activin A.

Market Segmentation

By Company

  • Merck Millipore
  • Thermo Fisher Scientific
  • Bio-Techne
  • StemRD
  • Prospec
  • Proteintech Group
  • Ajinomoto
  • Enzo Life Sciences
  • IBL
  • STEMCELL
  • Sino Biological
  • PeproTech
  • ReproCELL

Segment by Type

  • Activin-A Human
  • Activin-A Mouse (Rat)

Segment by Application

  • Commercial Research
  • Academic Research

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Activin A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Activin A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Activin A in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Activin A Product Introduction
  • 1.2 Global Activin A Market Size Forecast
    • 1.2.1 Global Activin A Sales Value (2020-2031)
    • 1.2.2 Global Activin A Sales Volume (2020-2031)
    • 1.2.3 Global Activin A Sales Price (2020-2031)
  • 1.3 Activin A Market Trends & Drivers
    • 1.3.1 Activin A Industry Trends
    • 1.3.2 Activin A Market Drivers & Opportunity
    • 1.3.3 Activin A Market Challenges
    • 1.3.4 Activin A Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Activin A Players Revenue Ranking (2024)
  • 2.2 Global Activin A Revenue by Company (2020-2025)
  • 2.3 Global Activin A Players Sales Volume Ranking (2024)
  • 2.4 Global Activin A Sales Volume by Company Players (2020-2025)
  • 2.5 Global Activin A Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Activin A Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Activin A Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Activin A
  • 2.9 Activin A Market Competitive Analysis
    • 2.9.1 Activin A Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Activin A Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Activin A as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Activin-A Human
    • 3.1.2 Activin-A Mouse (Rat)
  • 3.2 Global Activin A Sales Value by Type
    • 3.2.1 Global Activin A Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Activin A Sales Value, by Type (2020-2031)
    • 3.2.3 Global Activin A Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Activin A Sales Volume by Type
    • 3.3.1 Global Activin A Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Activin A Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Activin A Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Activin A Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Commercial Research
    • 4.1.2 Academic Research
  • 4.2 Global Activin A Sales Value by Application
    • 4.2.1 Global Activin A Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Activin A Sales Value, by Application (2020-2031)
    • 4.2.3 Global Activin A Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Activin A Sales Volume by Application
    • 4.3.1 Global Activin A Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Activin A Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Activin A Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Activin A Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Activin A Sales Value by Region
    • 5.1.1 Global Activin A Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Activin A Sales Value by Region (2020-2025)
    • 5.1.3 Global Activin A Sales Value by Region (2026-2031)
    • 5.1.4 Global Activin A Sales Value by Region (%), (2020-2031)
  • 5.2 Global Activin A Sales Volume by Region
    • 5.2.1 Global Activin A Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Activin A Sales Volume by Region (2020-2025)
    • 5.2.3 Global Activin A Sales Volume by Region (2026-2031)
    • 5.2.4 Global Activin A Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Activin A Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Activin A Sales Value, 2020-2031
    • 5.4.2 North America Activin A Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Activin A Sales Value, 2020-2031
    • 5.5.2 Europe Activin A Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Activin A Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Activin A Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Activin A Sales Value, 2020-2031
    • 5.7.2 South America Activin A Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Activin A Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Activin A Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Activin A Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Activin A Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Activin A Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Activin A Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Activin A Sales Value, 2020-2031
    • 6.3.2 United States Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Activin A Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Activin A Sales Value, 2020-2031
    • 6.4.2 Europe Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Activin A Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Activin A Sales Value, 2020-2031
    • 6.5.2 China Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Activin A Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Activin A Sales Value, 2020-2031
    • 6.6.2 Japan Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Activin A Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Activin A Sales Value, 2020-2031
    • 6.7.2 South Korea Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Activin A Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Activin A Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Activin A Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Activin A Sales Value, 2020-2031
    • 6.9.2 India Activin A Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Activin A Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Merck Millipore
    • 7.1.1 Merck Millipore Company Information
    • 7.1.2 Merck Millipore Introduction and Business Overview
    • 7.1.3 Merck Millipore Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Merck Millipore Activin A Product Offerings
    • 7.1.5 Merck Millipore Recent Development
  • 7.2 Thermo Fisher Scientific
    • 7.2.1 Thermo Fisher Scientific Company Information
    • 7.2.2 Thermo Fisher Scientific Introduction and Business Overview
    • 7.2.3 Thermo Fisher Scientific Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Thermo Fisher Scientific Activin A Product Offerings
    • 7.2.5 Thermo Fisher Scientific Recent Development
  • 7.3 Bio-Techne
    • 7.3.1 Bio-Techne Company Information
    • 7.3.2 Bio-Techne Introduction and Business Overview
    • 7.3.3 Bio-Techne Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Bio-Techne Activin A Product Offerings
    • 7.3.5 Bio-Techne Recent Development
  • 7.4 StemRD
    • 7.4.1 StemRD Company Information
    • 7.4.2 StemRD Introduction and Business Overview
    • 7.4.3 StemRD Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 StemRD Activin A Product Offerings
    • 7.4.5 StemRD Recent Development
  • 7.5 Prospec
    • 7.5.1 Prospec Company Information
    • 7.5.2 Prospec Introduction and Business Overview
    • 7.5.3 Prospec Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Prospec Activin A Product Offerings
    • 7.5.5 Prospec Recent Development
  • 7.6 Proteintech Group
    • 7.6.1 Proteintech Group Company Information
    • 7.6.2 Proteintech Group Introduction and Business Overview
    • 7.6.3 Proteintech Group Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Proteintech Group Activin A Product Offerings
    • 7.6.5 Proteintech Group Recent Development
  • 7.7 Ajinomoto
    • 7.7.1 Ajinomoto Company Information
    • 7.7.2 Ajinomoto Introduction and Business Overview
    • 7.7.3 Ajinomoto Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Ajinomoto Activin A Product Offerings
    • 7.7.5 Ajinomoto Recent Development
  • 7.8 Enzo Life Sciences
    • 7.8.1 Enzo Life Sciences Company Information
    • 7.8.2 Enzo Life Sciences Introduction and Business Overview
    • 7.8.3 Enzo Life Sciences Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Enzo Life Sciences Activin A Product Offerings
    • 7.8.5 Enzo Life Sciences Recent Development
  • 7.9 IBL
    • 7.9.1 IBL Company Information
    • 7.9.2 IBL Introduction and Business Overview
    • 7.9.3 IBL Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 IBL Activin A Product Offerings
    • 7.9.5 IBL Recent Development
  • 7.10 STEMCELL
    • 7.10.1 STEMCELL Company Information
    • 7.10.2 STEMCELL Introduction and Business Overview
    • 7.10.3 STEMCELL Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 STEMCELL Activin A Product Offerings
    • 7.10.5 STEMCELL Recent Development
  • 7.11 Sino Biological
    • 7.11.1 Sino Biological Company Information
    • 7.11.2 Sino Biological Introduction and Business Overview
    • 7.11.3 Sino Biological Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Sino Biological Activin A Product Offerings
    • 7.11.5 Sino Biological Recent Development
  • 7.12 PeproTech
    • 7.12.1 PeproTech Company Information
    • 7.12.2 PeproTech Introduction and Business Overview
    • 7.12.3 PeproTech Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 PeproTech Activin A Product Offerings
    • 7.12.5 PeproTech Recent Development
  • 7.13 ReproCELL
    • 7.13.1 ReproCELL Company Information
    • 7.13.2 ReproCELL Introduction and Business Overview
    • 7.13.3 ReproCELL Activin A Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 ReproCELL Activin A Product Offerings
    • 7.13.5 ReproCELL Recent Development

8 Industry Chain Analysis

  • 8.1 Activin A Industrial Chain
  • 8.2 Activin A Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Activin A Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Activin A Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Activin A Market Trends
  • Table 2. Activin A Market Drivers & Opportunity
  • Table 3. Activin A Market Challenges
  • Table 4. Activin A Market Restraints
  • Table 5. Global Activin A Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Activin A Revenue Market Share by Company (2020-2025)
  • Table 7. Global Activin A Sales Volume by Company (2020-2025) & (mg)
  • Table 8. Global Activin A Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Activin A Price by Company (2020-2025) & (US$/mg)
  • Table 10. Key Manufacturers Activin A Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Activin A Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Activin A
  • Table 13. Global Activin A Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Activin A as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Activin A Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Activin A Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Activin A Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Activin A Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Activin A Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Activin A Sales Volume by Type: 2020 VS 2024 VS 2031 (mg)
  • Table 22. Global Activin A Sales Volume by Type (2020-2025) & (mg)
  • Table 23. Global Activin A Sales Volume by Type (2026-2031) & (mg)
  • Table 24. Global Activin A Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Activin A Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Activin A Price by Type (2020-2025) & (US$/mg)
  • Table 27. Global Activin A Price by Type (2026-2031) & (US$/mg)
  • Table 28. Global Activin A Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Activin A Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Activin A Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Activin A Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Activin A Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Activin A Sales Volume by Application: 2020 VS 2024 VS 2031 (mg)
  • Table 34. Global Activin A Sales Volume by Application (2020-2025) & (mg)
  • Table 35. Global Activin A Sales Volume by Application (2026-2031) & (mg)
  • Table 36. Global Activin A Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Activin A Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Activin A Price by Application (2020-2025) & (US$/mg)
  • Table 39. Global Activin A Price by Application (2026-2031) & (US$/mg)
  • Table 40. Global Activin A Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Activin A Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Activin A Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Activin A Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Activin A Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Activin A Sales Volume by Region (mg): 2020 VS 2024 VS 2031
  • Table 46. Global Activin A Sales Volume by Region (2020-2025) & (mg)
  • Table 47. Global Activin A Sales Volume by Region (2026-2031) & (mg)
  • Table 48. Global Activin A Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Activin A Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Activin A Average Price by Region (2020-2025) & (US$/mg)
  • Table 51. Global Activin A Average Price by Region (2026-2031) & (US$/mg)
  • Table 52. Key Countries/Regions Activin A Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Activin A Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Activin A Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Activin A Sales Volume, (2020-2025) & (mg)
  • Table 56. Key Countries/Regions Activin A Sales Volume, (2026-2031) & (mg)
  • Table 57. Merck Millipore Company Information
  • Table 58. Merck Millipore Introduction and Business Overview
  • Table 59. Merck Millipore Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 60. Merck Millipore Activin A Product Offerings
  • Table 61. Merck Millipore Recent Development
  • Table 62. Thermo Fisher Scientific Company Information
  • Table 63. Thermo Fisher Scientific Introduction and Business Overview
  • Table 64. Thermo Fisher Scientific Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 65. Thermo Fisher Scientific Activin A Product Offerings
  • Table 66. Thermo Fisher Scientific Recent Development
  • Table 67. Bio-Techne Company Information
  • Table 68. Bio-Techne Introduction and Business Overview
  • Table 69. Bio-Techne Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 70. Bio-Techne Activin A Product Offerings
  • Table 71. Bio-Techne Recent Development
  • Table 72. StemRD Company Information
  • Table 73. StemRD Introduction and Business Overview
  • Table 74. StemRD Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 75. StemRD Activin A Product Offerings
  • Table 76. StemRD Recent Development
  • Table 77. Prospec Company Information
  • Table 78. Prospec Introduction and Business Overview
  • Table 79. Prospec Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 80. Prospec Activin A Product Offerings
  • Table 81. Prospec Recent Development
  • Table 82. Proteintech Group Company Information
  • Table 83. Proteintech Group Introduction and Business Overview
  • Table 84. Proteintech Group Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 85. Proteintech Group Activin A Product Offerings
  • Table 86. Proteintech Group Recent Development
  • Table 87. Ajinomoto Company Information
  • Table 88. Ajinomoto Introduction and Business Overview
  • Table 89. Ajinomoto Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 90. Ajinomoto Activin A Product Offerings
  • Table 91. Ajinomoto Recent Development
  • Table 92. Enzo Life Sciences Company Information
  • Table 93. Enzo Life Sciences Introduction and Business Overview
  • Table 94. Enzo Life Sciences Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 95. Enzo Life Sciences Activin A Product Offerings
  • Table 96. Enzo Life Sciences Recent Development
  • Table 97. IBL Company Information
  • Table 98. IBL Introduction and Business Overview
  • Table 99. IBL Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 100. IBL Activin A Product Offerings
  • Table 101. IBL Recent Development
  • Table 102. STEMCELL Company Information
  • Table 103. STEMCELL Introduction and Business Overview
  • Table 104. STEMCELL Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 105. STEMCELL Activin A Product Offerings
  • Table 106. STEMCELL Recent Development
  • Table 107. Sino Biological Company Information
  • Table 108. Sino Biological Introduction and Business Overview
  • Table 109. Sino Biological Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 110. Sino Biological Activin A Product Offerings
  • Table 111. Sino Biological Recent Development
  • Table 112. PeproTech Company Information
  • Table 113. PeproTech Introduction and Business Overview
  • Table 114. PeproTech Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 115. PeproTech Activin A Product Offerings
  • Table 116. PeproTech Recent Development
  • Table 117. ReproCELL Company Information
  • Table 118. ReproCELL Introduction and Business Overview
  • Table 119. ReproCELL Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
  • Table 120. ReproCELL Activin A Product Offerings
  • Table 121. ReproCELL Recent Development
  • Table 122. Key Raw Materials Lists
  • Table 123. Raw Materials Key Suppliers Lists
  • Table 124. Activin A Downstream Customers
  • Table 125. Activin A Distributors List
  • Table 126. Research Programs/Design for This Report
  • Table 127. Key Data Information from Secondary Sources
  • Table 128. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Activin A Product Picture
  • Figure 2. Global Activin A Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Activin A Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Activin A Sales Volume (2020-2031) & (mg)
  • Figure 5. Global Activin A Sales Price (2020-2031) & (US$/mg)
  • Figure 6. Activin A Report Years Considered
  • Figure 7. Global Activin A Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Activin A Players Sales Volume Ranking (2024) & (mg)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Activin A Revenue in 2024
  • Figure 10. Activin A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Activin-A Human Picture
  • Figure 12. Activin-A Mouse (Rat) Picture
  • Figure 13. Global Activin A Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Activin A Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Activin A Sales Volume by Type (2020 VS 2024 VS 2031) & (mg)
  • Figure 16. Global Activin A Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Activin A Price by Type (2020-2031) & (US$/mg)
  • Figure 18. Product Picture of Commercial Research
  • Figure 19. Product Picture of Academic Research
  • Figure 20. Global Activin A Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 21. Global Activin A Sales Value Market Share by Application, 2024 & 2031
  • Figure 22. Global Activin A Sales Volume by Application (2020 VS 2024 VS 2031) & (mg)
  • Figure 23. Global Activin A Sales Volume Market Share by Application, 2024 & 2031
  • Figure 24. Global Activin A Price by Application (2020-2031) & (US$/mg)
  • Figure 25. North America Activin A Sales Value (2020-2031) & (US$ Million)
  • Figure 26. North America Activin A Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Europe Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Europe Activin A Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Asia Pacific Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Asia Pacific Activin A Sales Value by Region (%), 2024 VS 2031
  • Figure 31. South America Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. South America Activin A Sales Value by Country (%), 2024 VS 2031
  • Figure 33. Middle East & Africa Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Middle East & Africa Activin A Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Key Countries/Regions Activin A Sales Value (%), (2020-2031)
  • Figure 36. Key Countries/Regions Activin A Sales Volume (%), (2020-2031)
  • Figure 37. United States Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. United States Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 39. United States Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Europe Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Europe Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Europe Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 43. China Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. China Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 45. China Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Japan Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Japan Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Japan Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 49. South Korea Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. South Korea Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 51. South Korea Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Southeast Asia Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. Southeast Asia Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 54. Southeast Asia Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 55. India Activin A Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. India Activin A Sales Value by Type (%), 2024 VS 2031
  • Figure 57. India Activin A Sales Value by Application (%), 2024 VS 2031
  • Figure 58. Activin A Industrial Chain
  • Figure 59. Activin A Manufacturing Cost Structure
  • Figure 60. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 61. Bottom-up and Top-down Approaches for This Report
  • Figure 62. Data Triangulation
  • Figure 63. Key Executives Interviewed